Close

Veltuzumab (TAB-881)

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human MS4A1/CD20 Therapeutic Antibody TAB-881 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant human monoclonal antibody expressed in CHO binding to human CD20. Veltuzumab is a monoclonal antibody which is being investigated for the treatment of non-Hodgkin's lymphoma.
  • Target
  • CD20
  • Type
  • IgG1
  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, ICC and most other immunological methods.
  • CAS
  • 728917-18-8
  • Predicted N terminal
  • QVQLQQSG
  • Molecular Weight
  • 145.3 kDa
  • Purity
  • >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
  • Size
  • 1mg
  • Storage
  • 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.

BACKGROUND

  • Introduction
  • Veltuzumab is a monoclonal antibody which is being investigated for the treatment of non-Hodgkin's lymphoma.
  • Antigen Description
  • This gene is B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells.
  • Function
  • epidermal growth factor receptor binding;
  • Synonyms
  • MS4A1; membrane-spanning 4-domains, subfamily A, member 1; CD20; B-lymphocyte antigen CD20; B1; Bp35; MS4A2; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1; S7; CVID5; LEU-16; MGC3969;

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us